Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection

被引:65
作者
Kaku, Chengzi, I [1 ]
Bergeron, Alan J. [2 ,3 ]
Ahlm, Clas [4 ]
Normark, Johan [4 ]
Sakharkar, Mrunal [1 ]
Forsell, Mattias N. E. [4 ]
Walker, Laura M. [5 ]
机构
[1] Adimab LLC, Lebanon, NH 03766 USA
[2] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA
[3] Dartmouth Coll, Dept Microbiol & Immunol, Hanover, NH 03755 USA
[4] Umea Univ, Dept Clin Microbiol, Div Immunol, Umea, Sweden
[5] Adagio Therapeut Inc, Waltham, MA 02451 USA
基金
瑞典研究理事会;
关键词
SARS-COV-2; VACCINATION; RESPONSES; POTENT;
D O I
10.1126/sciimmunol.abq3511
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Understanding immune responses after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection will facilitate the development of next-generation vaccines. Here, we profiled spike (S)-specific B cell responses after Omicron/BA.1 infection in messenger RNA-vaccinated donors. The acute antibody response was characterized by high levels of somatic hypermutation and a bias toward recognition of ancestral SARS-CoV-2 strains, suggesting the early activation of vaccine-induced memory B cells. BA.1 breakthrough infection induced a shift in B cell immunodominance hierarchy from the S2 subunit, which is highly conserved across SARS-CoV-2 variants of concern (VOCs), and toward the antigenically variable receptor binding domain (RBD). A large proportion of RBD-directed neutralizing antibodies isolated from BA.1 breakthrough infection donors displayed convergent sequence features and broadly recognized SARS-CoV-2 VOCs. Together, these findings provide insights into the role of preexisting immunity in shaping the B cell response to heterologous SARS-CoV-2 variant exposure.
引用
收藏
页数:12
相关论文
共 44 条
[1]   Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants [J].
Abu-Raddad, Laith J. ;
Chemaitelly, Hiam ;
Butt, Adeel A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02) :187-189
[2]  
Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]
[3]   Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans [J].
Andrews, Sarah F. ;
Joyce, M. Gordon ;
Chambers, Michael J. ;
Gillespie, Rebecca A. ;
Kanekiyo, Masaru ;
Leung, Kwanyee ;
Yang, Eun Sung ;
Tsybovsky, Yaroslav ;
Wheatley, Adam K. ;
Crank, Michelle C. ;
Boyington, Jeffrey C. ;
Prabhakaran, Madhu S. ;
Narpala, Sandeep R. ;
Chen, Xuejun ;
Bailer, Robert T. ;
Chen, Grace ;
Coates, Emily ;
Kwong, Peter D. ;
Koup, Richard A. ;
Mascola, John R. ;
Graham, Barney S. ;
Ledgerwood, Julie E. ;
McDermott, Adrian B. .
SCIENCE IMMUNOLOGY, 2017, 2 (13)
[4]   Defining B cell immunodominance to viruses [J].
Angeletti, Davide ;
Gibbs, James S. ;
Angel, Matthew ;
Kosik, Ivan ;
Hickman, Heather D. ;
Frank, Gregory M. ;
Das, Suman R. ;
Wheatley, Adam K. ;
Prabhakaran, Madhu ;
Leggat, David J. ;
McDermott, Adrian B. ;
Yewdell, Jonathan W. .
NATURE IMMUNOLOGY, 2017, 18 (04) :456-+
[5]   SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies [J].
Barnes, Christopher O. ;
Jette, Claudia A. ;
Abernathy, Morgan E. ;
Dam, Kim-Marie A. ;
Esswein, Shannon R. ;
Gristick, Harry B. ;
Malyutin, Andrey G. ;
Sharaf, Naima G. ;
Huey-Tubman, Kathryn E. ;
Lee, Yu E. ;
Robbiani, Davide F. ;
Nussenzweig, Michel C. ;
West, Anthony P., Jr. ;
Bjorkman, Pamela J. .
NATURE, 2020, 588 (7839) :682-+
[6]   Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection [J].
Bates, Timothy A. ;
McBride, Savannah K. ;
Winders, Bradie ;
Schoen, Devin ;
Trautmann, Lydie ;
Curlin, Marcel E. ;
Tafesse, Fikadu G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (02) :179-181
[7]   Commonality despite exceptional diversity in the baseline human antibody repertoire [J].
Briney, Bryan ;
Inderbitzin, Anne ;
Joyce, Collin ;
Burton, Dennis R. .
NATURE, 2019, 566 (7744) :393-+
[8]  
Cao Y., 2022, NATURE
[9]  
Chemaitelly H., 2022, NAT COMMUN
[10]   Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis [J].
Choi, Angela ;
Koch, Matthew ;
Wu, Kai ;
Chu, Laurence ;
Ma, LingZhi ;
Hill, Anna ;
Nunna, Naveen ;
Huang, Wenmei ;
Oestreicher, Judy ;
Colpitts, Tonya ;
Bennett, Hamilton ;
Legault, Holly ;
Paila, Yamuna ;
Nestorova, Biliana ;
Ding, Baoyu ;
Montefiori, David ;
Pajon, Rolando ;
Miller, Jacqueline M. ;
Leav, Brett ;
Carfi, Andrea ;
McPhee, Roderick ;
Edwards, Darin K. .
NATURE MEDICINE, 2021, 27 (11) :2025-+